Integer (NYSE:ITGR) was downgraded by stock analysts at TheStreet from a "b" rating to a "c+" rating in a research report issued on Thursday, TheStreetRatingsTable reports.
ITGR has been the subject of several other reports. Benchmark began coverage on Integer in a report on Thursday, May 14th. They set a "buy" rating and a $105.00 price objective for the company. Sidoti raised their price target on Integer from $100.00 to $108.00 and gave the stock a "buy" rating in a research report on Friday, May 8th. ValuEngine raised Integer from a "sell" rating to a "hold" rating in a research report on Friday, May 8th. Finally, KeyCorp dropped their price target on Integer from $90.00 to $87.00 and set an "overweight" rating for the company in a research report on Friday, May 8th. One investment analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. The stock presently has an average rating of "Buy" and a consensus price target of $100.00.
ITGR opened at $65.77 on Thursday. The company has a debt-to-equity ratio of 0.82, a current ratio of 3.77 and a quick ratio of 1.56. The business has a 50 day simple moving average of $71.16 and a 200-day simple moving average of $76.18. The stock has a market capitalization of $2.24 billion, a P/E ratio of 29.90 and a beta of 1.20. Integer has a 12 month low of $46.01 and a 12 month high of $99.95.
Integer (NYSE:ITGR) last posted its quarterly earnings results on Thursday, July 30th. The medical equipment provider reported $0.32 EPS for the quarter, missing the consensus estimate of $0.40 by ($0.08). The business had revenue of $240.12 million during the quarter, compared to analyst estimates of $235.70 million. Integer had a net margin of 6.10% and a return on equity of 11.48%. Research analysts anticipate that Integer will post 3.36 EPS for the current year.
Institutional investors have recently added to or reduced their stakes in the business. Norges Bank purchased a new position in Integer during the fourth quarter worth $32,239,000. Russell Investments Group Ltd. grew its position in shares of Integer by 2.9% in the first quarter. Russell Investments Group Ltd. now owns 86,204 shares of the medical equipment provider's stock valued at $5,417,000 after purchasing an additional 2,406 shares during the period. Parametric Portfolio Associates LLC grew its position in shares of Integer by 4.2% in the first quarter. Parametric Portfolio Associates LLC now owns 126,446 shares of the medical equipment provider's stock valued at $7,948,000 after purchasing an additional 5,072 shares during the period. Geode Capital Management LLC grew its position in shares of Integer by 3.3% in the first quarter. Geode Capital Management LLC now owns 510,076 shares of the medical equipment provider's stock valued at $32,062,000 after purchasing an additional 16,246 shares during the period. Finally, Envestnet Asset Management Inc. grew its position in shares of Integer by 244.6% in the second quarter. Envestnet Asset Management Inc. now owns 49,946 shares of the medical equipment provider's stock valued at $3,649,000 after purchasing an additional 35,454 shares during the period. 98.11% of the stock is owned by institutional investors.
Integer Holdings Corporation operates as a medical device outsource manufacturer worldwide. It operates in two segments, Medical and Non-Medical. The company offers products for vascular, cardiac surgery, and structural heart diseases; peripheral vascular, neurovascular, urology, and oncology products; and electrophysiology, infusion therapy, and hemodialysis products.
Featured Article: Support Level
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected]
7 Energy Stocks to Buy On This Historical Dip
It may seem hard to believe, but the current chaos in the energy sector, and oil stocks, in particular, will pass. The novel coronavirus that has birthed a global pandemic is being compared to the Spanish Flu of 1918.
Of course, when you have once in a century event, it’s difficult to look back in history and make an apples-to-apples comparison to our current situation. This isn’t to minimize our current situation. It’s simply to say that the market is forward-looking, but it’s also emotional. And it also hates uncertainty.
In a typical economic downturn, demand decreases, and investors are advised to “buy the dip.” But in the current environment, demand has been destroyed. Millions of Americans are being asked, and in some cases ordered, to stay home. And this simply means that oil demand is down. And investors are looking at prices that are, in some cases, at all-time lows.
The trading app Robinhood is frequented by millennial investors. And according to the latest information, many investors are trying to buy the dip on old guard oil stocks. That may be a mistake.
But the energy sector is about more than just oil stocks. There are several companies that are holding their own in the current environment. And that means when the economy opens up, these companies will be well-positioned for further growth.
Currently, the volatility and uncertainty surrounding energy stocks make them a poor choice for growth investors. However, many of these companies in this presentation offer a secure dividend that, along with the potential for capital appreciation, can make them a solid play for income investors.
View the "7 Energy Stocks to Buy On This Historical Dip".